CLVS
Clovis Oncology Inc
Price:  
0.08 
USD
Volume:  
24,516,500.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CLVS WACC - Weighted Average Cost of Capital

The WACC of Clovis Oncology Inc (CLVS) is 7.0%.

The Cost of Equity of Clovis Oncology Inc (CLVS) is 84.45%.
The Cost of Debt of Clovis Oncology Inc (CLVS) is 5.50%.

Range Selected
Cost of equity 55.30% - 113.60% 84.45%
Tax rate 0.20% - 0.20% 0.20%
Cost of debt 4.00% - 7.00% 5.50%
WACC 5.0% - 9.0% 7.0%
WACC

CLVS WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 5.0% 6.0%
Adjusted beta 10.22 18.07
Additional risk adjustments 0.0% 0.5%
Cost of equity 55.30% 113.60%
Tax rate 0.20% 0.20%
Debt/Equity ratio 52.27 52.27
Cost of debt 4.00% 7.00%
After-tax WACC 5.0% 9.0%
Selected WACC 7.0%